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H~ technology of gene targeting is still in its infancy, 
but one astonishing theme is being seen over and over. 
Disruption of a supposedly important gene frequently 
produces a minimal phenotype. In some cases a phenotype 
is discovered in an unexpected tissue, but there is no dis- 
ruption  of the  tissues  where  the  protein  is  most  highly 
expressed, and where its function was thought to be most im- 
portant.  A frequent explanation is that proteins are "redun- 
dant," in the sense that closely related proteins with dupli- 
cated functions might fill in for the one eliminated. However, 
the word redundant can also be used to mean superfluous, 
and this may be the more appropriate sense. Coexpression 
of proteins with duplicated functions is probably superfluous 
and wasteful but,  as argued below, may be tolerated.  The 
more extreme view of superfluous expression is that proteins 
may be prominently expressed in cells or tissues where they 
have no function at all. 
Over the last decade many proteins have been discovered 
through  cloning or antibodies,  leaving the investigators to 
determine the function. The search for function frequently 
begins with immunocytochemistry, to determine where and 
when the protein is expressed. The interpretation,  that the 
protein is playing an important role at the sites where it is 
most prominently  expressed,  is almost universal.  If, how- 
ever, proteins are expressed superfluously, where they have 
no function, these interpretations  need to be re-evaluated. 
Three Gene Knockouts Suggesting Superfluous 
Protein Expression 
The c-src protein (9,  15) is a tyrosine kinase that is most 
prominently  expressed  in  platelets,  where  it  constitutes 
0.2-0.4%  of the total protein,  and in neurons,  where two 
splice variants are differentially expressed and concentrated 
in the growth cones. When the c-src gene was totally dis- 
rupted in mice (15), the expectation was that the homozygous 
null mice would have severe and probably lethal defects in 
platelets and the nervous system. Surprisingly, these tissues 
appeared completely normal.  The mice without c-src did 
suffer a severe phenotype, osteopetrosis, and it was soon dis- 
covered that  c-src was also prominently  expressed  in  os- 
teoclasts (4a,  9).  Presumably c-src is playing an essential 
role in osteoclast function. But what is the role of c-src in 
platelets and neurons, tissues in which it is also prominently 
expressed, but apparently dispensable? 
Transforming growth factor (TGF)I-/51, -t52, and -/33 are 
a family of closely related protein growth factors. These iso- 
forms are prominently expressed in specific patterns in many 
embryonic tissues,  largely overlapping but sometimes dis- 
tinct (7,  10). TGF-/3s are also expressed in many cell types 
and extracellular matrix locations of adults, but most atten- 
tion has focused on the embryonic expression, with the ex- 
pectation that each isoform is playing vital roles in develop- 
ment.  Numerous studies in ceil culture have demonstrated 
powerful stimulatory and inhibitory effects on ceil function, 
building on the expectation that TGF-/3s will have an impor- 
tant role wherever they are expressed. Surprisingly, the re- 
cent gene knockout of TGF-/31 (14) gave mice that were born 
with no apparent defect in development. They did develop 
severe, multifocal inflammatory disease after birth and die 
at ~,20 d of age, confirming the essential role of TGF-/31 in 
modulating the inflammatory response. But what is the role 
of TGF-/31 in the several embryonic tissues where it is ex- 
pressed prominently and in specific patterns? 
Tenascin (3) is a large extracellular matrix protein expressed 
in specific patterns  in developing brain,  cartilage,  smooth 
muscle,  and in several tissues involving epithelial-mesen- 
chymal interactions. Tenascin is prominently re-expressed in 
many tumors  and in heating  wounds.  Two tenascin  para- 
logues (related genes) are known, but their expression pat- 
terns show only limited overlap (4, 6, 8, 11; ref. 4 also dem- 
onstrates a recent duplication of tenascin gene X, producing 
a large tenascin XB protein and a severely truncated XA). 
The multi-domain structure of the tenascin subunit and the 
regulated expression of splice variants, suggested the possi- 
bility  of multiple,  independent  functions,  each  of which 
could be essential in one or more tissues in which tenascin 
is expressed. Indeed, some of us thought that the gene target- 
ing of tenascin should be approached piecemeal, knocking 
out one or a small cluster of domains at a time to determine 
separately the multiple functions. However, the bolder knock- 
out of the entire tenascin gene was done first, with the amaz- 
ing conclusion that "Mice develop normany without tenas- 
cin" (13). What is the role of the tenascin in the embryonic 
tissues where it is prominently expressed with such precise 
temporal and spatial regulation? 
The answer in all three cases may be-no functional role 
at all. A key assumption in interpreting immunolocalization, 
L Abbre~aions used in tttspaper: NGF, nerve growth factor; TGF, trans- 
forming gmvah factor. 
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may be misleading. 
Superfluous Expression of Nerve Growth Factor 
and EGF 
Nerve growth factor (NGF, reviewed in 16) was first identi- 
fied by its extremely potent activity in stimulating the growth 
of neurons. Research was greatly facilitated by the surprising 
discovery that NGF is highly concentrated in the submaxil- 
lary glands of adult male mice. It is specifically localized to 
the granular convoluted tubule cells, and is secreted in the 
saliva rather than in an endocrine fashion. EGF is also ex- 
pressed at extremely high concentration in these submaxil- 
lary glands. Neither protein is expressed in female mice, nor 
in male or female rats, nor in the salivary glands of most 
other species. Curiously, NGF is also expressed in high con- 
centration in the prostate gland of guinea pig, rabbit and 
bull, but not in rat, mouse, hamster, or human (16). 
Despite many efforts, no function has been found for NGF 
in these male excretory glands. Indeed, it is difficult  to imag- 
ine a function for NGF in male mouse saliva, a function not 
needed in female mice nor in rats, but somehow used in the 
semen of three unrelated mammals. I suggest that this may 
be another example of superfluous protein expression, with 
no function in the tissue of highest expression. 
Several Possibilities  for Apparent 
Nonfunctional Expression 
There are several possible reasons why deletion of a promi- 
nently expressed protein might be benign. The first three 
listed here have already been discussed substantially (see es- 
pecially ref. 2 for a brief but elegant analysis). 
First, the protein could have a modest, rather than a vital 
function. A gene can become fixed in a population if it pro- 
vides only a small survival advantage, which might be unde- 
tectable in a laboratory animal. 
Second, it is possible that loss of a protein might up-regu- 
late  compensatory pathways, which could be  affected by 
common feedback mechanisms. This has been argued in a 
recent gene knockout of the myo-D protein (12). 
Third, the usual concept of redundancy: coexpression of 
proteins with duplicated functions. This has been convinc- 
ingly argued as the reason for minimal phenotype in several 
cases of gene knockout (1, 2, 5, 12, 14, 15), and is probably 
important in many systems. If several proteins with similar 
functions are coexpressed in the same cell or tissue, knock- 
ing out any one of them may have no effect on that tissue. 
Fourth, proteins may be expressed in tissues where they 
have no function at all. A rationale for this, applying also to 
the  coexpression  of  related  proteins,  will  be  developed 
below. 
Why Turn It Off  lf  lt Doesn't Hurt? 
It is clearly essential that a gene must be turned on where 
the protein is needed, but the converse is not necessarily 
true. How important would it be to switch off a gene in cells 
where it is not needed? One might suggest economy, and it 
is natural for the biochemist to regard proteins as precious 
commodities, not to be wasted. But from the perspective of 
cellular metabolism, protein synthesis is very cheap. Thus 
the energy required to synthesize the c-src in platelets, where 
it constitutes up to 0.4% of the total cellular protein, is only 
a tiny fraction of  the cell's overall metabolism, most of which 
goes to pumping ions. Even if c-src is totally useless in the 
platelet,  the cell can easily afford to make it.  Similarly, 
tenascin may be nonfunctional  in the embryonic brain tissues 
where it is prominently expressed, but the expense of secret- 
ing it is minimal. 
A truly important reason for turning off a gene would be 
if the protein were toxic or otherwise deleterious. Indeed, 
most proteins are probably deleterious in many places, and 
this is probably a major basis for the elaborate mechanisms 
for gene regulation. Also, some economy must be exercised 
not to have the protein synthesis machinery monopolized by 
thousands of useless proteins. But precise regulation need 
not apply to all proteins, even proteins that would appear to 
have a potent biological activity. Thus c-src might be toler- 
ated in platelets and neurons, and TGF-/~I in embryonic tis- 
sues,  if their  receptors  were  already  saturated by coex- 
pressed proteins. NGF and EGF are probably innocuous in 
saliva and semen because the secreted proteins do not con- 
tact receptors. The still unknown functions of tenascin may 
be unimportant in at least some embryonic tissues. 
The question remains, shouldn't useless proteins be turned 
off even if the expense of producing them is small? The an- 
swer probably lies in the economics of gene control mech- 
anisms-they are expensive. Certainly each protein cannot 
have its own private control mechanism.  The number of 
separate switches, i.e., transcription factors and the DNA 
elements they bind,  is necessarily much smaller than the 
number of proteins that need to be controlled. Even with 
combinations of switches a unique control for every protein 
is probably impossible. Moreover, it is probably unnecessary. 
It is no doubt much more expensive to provide a separate 
control mechanism than to make a little extra innocuous pro- 
tein. The control mechanisms themselves require synthesis 
of separate proteins, and their invention by evolution is not 
a trivial process. Rather than devising a unique control for 
every gene, evolution may have generated a more limited set 
of shared switches.  The rules governing the sharing would 
be that genes must have a switch to turn them on where the 
protein is needed, and they must be turned off (or not turned 
on) where they are toxic. Some overall economy is probably 
also needed, not to turn on too many useless proteins. But 
in any particular cell or tissue, one might expect to find pro- 
teins that are wastefully expressed, because one protein in 
a regulatory bank is needed and the others are not harmful. 
The two types of superfluous protein expression discussed 
here may both be accidents of evolution, and closely related. 
When related proteins with duplicate functions are coex- 
pressed, each of the proteins could exercise its function, but 
no one of them is essential. In the more extreme case a pro- 
tein may be expressed where its function is not used at all. 
In both cases the superfluous protein expression is somewhat 
wasteful but apparently not a sufficient burden to generate 
a new control mechanism that would turn it off. 
The concept of"junk  DNA" is widely accepted. We should 
perhaps now consider the possibility of"junk proteinY This 
should not imply that there are proteins without function 
(these would not be preserved by evolution), but refers to ex- 
pression where the function is not needed. Thus a protein 
might be considered  junk in any cell or tissue where its func- 
tions are duplicated by coexpressed relatives, or where its 
functions are not used. 
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covered after the src-deficient mice demonstrated a defect in 
bone resorption. The knockout of TGF-/31 suggests that its 
expression in embryos is nonvital, but dramatically confirms 
its essential role in modulating the inflammatory response in 
adults. Defects in tenascin-deficient mice have not yet been 
found, and the functions of tenascin are still unknown. Per- 
haps the search for function will be more fruitful as we turn 
our attention from the sites of prominent expression in em- 
bryos, and look for more subtle roles in a small set of em- 
bryonic or adult tissues. 
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